These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3201 related articles for article (PubMed ID: 18579353)

  • 21. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
    Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
    Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs.
    Debunne A; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2002 Nov; 54(3):343-8. PubMed ID: 12445566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vitro characterization of piroxicam enteric coated pellets using powder layering technique.
    Varshosaz J; Tavakoli N; Serri A
    Pharm Dev Technol; 2009; 14(3):305-11. PubMed ID: 19519183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):158-66. PubMed ID: 18499369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a multiple-unit tablet containing enteric-coated pellets.
    Dreu R; Ilić I; Srčič S
    Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of polysaccharide gel-coated pellets for oral administration: swelling and release behavior of calcium pectinate gel.
    Sriamornsak P; Kennedy RA
    AAPS PharmSciTech; 2007 Sep; 8(3):E79. PubMed ID: 17915829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
    Guan T; Wang J; Li G; Tang X
    Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
    Pai R; Kohli K; Jain G; Srivastava B
    Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 161.